Labcorp Holdings Inc. (LH) Stock
Fundamentals
Source: third-party data provider, as of October 9, 2026
Compare with LH
Recent news

Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
LH

Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
LH

Why Labcorp Holdings Stock Dropped Today
Why Labcorp Holdings Stock Dropped Today
LH

Great Point Partners III Sells MLM Medical Labs to Labcorp
Great Point Partners III Sells MLM Medical Labs to Labcorp
LH
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 50.27
- MACD 12/26/9
- -2.42
- EMA 9 of MACD
- -2.67
- MACD histogram
- 0.25
- SMA 50
- $319.90
- Price below SMA 50
- EMA 50
- $311.72
- Price above EMA 50
- SMA 200
- $281.49
- Price above SMA 200
- EMA 200
- $288.29
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 8, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 9 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $4.10 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
LH

Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
LH

Why Labcorp Holdings Stock Dropped Today
Why Labcorp Holdings Stock Dropped Today
LH

Great Point Partners III Sells MLM Medical Labs to Labcorp
Great Point Partners III Sells MLM Medical Labs to Labcorp
LH

Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
LH

Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
LH

Should You Continue to Hold Labcorp Stock in Your Portfolio?
Should You Continue to Hold Labcorp Stock in Your Portfolio?
LH

Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million
LH

Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
LH

Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
LH
News tone: automated (AI) classification of the article's content, not a price prediction.
About Labcorp Holdings Inc.
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and save lives.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Adam H. Schechter | President, CEO & Chairman | 1965 |
| Ms. Julia A. Wang | CFO & Executive VP | 1972 |
| Dr. Brian J. Caveney J.D., M.D., M.P.H. | Exec VP, President of Biopharma Laboratory Services & Chief Medical and Scientific Officer | 1974 |
| Mr. Jonathan C. Meltzer Ph.D. | EVP & Chief Operations Officer | — |
| Mr. Peter J. Wilkinson | Senior VP & Chief Accounting Officer | 1971 |
| Mr. Akinbolade Oyegunwa M.B.A., Ph.D. | Executive VP and Chief Information & Technology Officer | 1983 |
| Mr. Dewey Steadman C.F.A. | Senior Vice President of Investor Relations | — |
| Ms. Kathryn Wright Kyle | Executive VP, Chief Legal Officer and Corporate Secretary | 1971 |
| Ms. Amy B. Summy | EVP, Chief Marketing Officer & Consumer Health Lead | 1966 |
| Ms. Anita Z. Graham | Executive VP & Chief Human Resources Officer | 1971 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 9, 2026
Technical indicators
- RSI 14
- 50.27
- MACD 12/26/9
- -2.42
- EMA 9 of MACD
- -2.67
- MACD histogram
- 0.25
- SMA 50
- $319.90
- Price below SMA 50
- EMA 50
- $311.72
- Price above EMA 50
- SMA 200
- $281.49
- Price above SMA 200
- EMA 200
- $288.29
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 8, 2026. Technical data, not a recommendation.
Analyst views
9 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $309.00
- Average
- $340.00
- High
- $380.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +4.7 | -1.2 | +10.1 | |||||||||
| 2022 | -9.0 | -0.6 | -2.0 | -8.7 | +1.5 | -4.6 | +8.8 | -12.7 | -9.8 | +4.7 | +8.2 | -2.6 |
| 2023 | +6.0 | -4.3 | -3.6 | -1.6 | -7.5 | +13.6 | +2.4 | -2.6 | -2.7 | +0.1 | +6.4 | +3.8 |
| 2024 | -4.4 | -3.8 | +0.2 | -6.9 | -3.2 | +4.4 | +6.1 | -1.5 | -2.7 | +4.1 | +6.2 | -4.7 |
| 2025 | +9.5 | +1.3 | -8.4 | +3.6 | +3.2 | +5.9 | -1.6 | +6.3 | +4.9 | -9.0 | +4.2 | -6.3 |
| 2026 | +7.9 | +7.0 | -6.9 | -5.8 | +1.6 | +9.0 | +8.9 | +8.2 | -6.0 | +3.2 |
Corporate actions
Upcoming
No upcoming corporate actions for LH



